| Announce Date | 11/10/2025 |
| EPS Normalized Actual | $-0.21 (Beat by $0.02) |
| EPS GAAP Actual | $-0.21 (Beat by $0.02) |
| Revenue Actual | $0.066606B |
| Revenue Surprise | Beat by $66.606M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.03 |
| EPS GAAP Estimate | $0.03 |
| Revenue Estimate | $0.116488982B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2026 | 0.8 | 10.36 | 0.8 | 0.8 | 0 |
| Dec 2025 | 0.03 | 276.33 | 0.03 | 0.03 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -2.35 | -2.61 | 0.066606B | -71.16% | -46.48M |
| FQ2 2025 (Jun 2025) | -0.44 | -0.54 | 0.054957B | -91.06% | -132.54M |
| FQ1 2025 (Mar 2025) | -1.22 | -1.46 | 0.062756B | -67.31% | -105.99M |
| FQ4 2024 (Dec 2024) | -11.677 | -11.677 | -0.085185B | 188.04% | -85.19M |
| FQ3 2024 (Sep 2024) | 0.0419 | 0.0419 | 0.114B | 35.09% | 114M |
| FQ2 2024 (Jun 2024) | -0.0216 | -0.0216 | 0.105B | 40.95% | 105M |
| FQ1 2024 (Mar 2024) | 0.44 | 0.44 | 0.105B | 45.71% | 105M |
| FQ4 2023 (Dec 2023) | -0.24 | -0.24 | 0.075B | -160% | 75M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.03
Consensus Revenue Estimates
0.116488982B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.26 | -- | 0.26 | 0.26 | 1 |
| FQ3 2027 (Sep 2027) | 0.15 | -- | 0.15 | 0.15 | 1 |
| FQ2 2027 (Jun 2027) | 0.06 | -- | 0.06 | 0.06 | 1 |
| FQ1 2027 (Mar 2027) | 0.19 | -- | 0.19 | 0.19 | 1 |
| FQ4 2026 (Dec 2026) | 0.04 | -- | 0.04 | 0.04 | 0 |
| FQ3 2026 (Sep 2026) | 0.01 | 23600 | 0.01 | 0.01 | 0 |
| FQ2 2026 (Jun 2026) | 0.01 | 4500 | 0.01 | 0.01 | 0 |
| FQ1 2026 (Mar 2026) | 0.03 | 4166.67 | 0.03 | 0.03 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.02B | -- | 0.02B | 0.02B | 1 |
| FQ3 2027 (Sep 2027) | 0.02B | -- | 0.02B | 0.02B | 1 |
| FQ2 2027 (Jun 2027) | 0.02B | -- | 0.02B | 0.02B | 1 |
| FQ1 2027 (Mar 2027) | 0.02B | -- | 0.02B | 0.02B | 1 |
| FQ4 2026 (Dec 2026) | 0.12B | -- | 0.12B | 0.12B | 0 |
| FQ3 2026 (Sep 2026) | 0.12B | 44.49 | 0.12B | 0.12B | 0 |
| FQ2 2026 (Jun 2026) | 0.12B | 53.52 | 0.12B | 0.12B | 0 |
| FQ1 2026 (Mar 2026) | 0.12B | 46.13 | 0.12B | 0.12B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
4
Revenue # of Misses
4
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.26 | -2.35 | -2.61 | 111.06% |
| FQ2 2025 (Jun 2025) | 0.1 | -0.44 | -0.54 | 122.73% |
| FQ1 2025 (Mar 2025) | 0.24 | -1.22 | -1.46 | 119.67% |
| FQ4 2024 (Dec 2024) | -11.677 | -11.677 | 100% | |
| FQ3 2024 (Sep 2024) | 0.0419 | 0.0419 | 100% | |
| FQ2 2024 (Jun 2024) | -0.0216 | -0.0216 | 100% | |
| FQ1 2024 (Mar 2024) | 0.44 | 0.44 | 100% | |
| FQ4 2023 (Dec 2023) | -0.24 | -0.24 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.11B | $0.07B | $-46.48M | -69.78% |
| FQ2 2025 (Jun 2025) | $0.19B | $0.05B | $-132.54M | -241.18% |
| FQ1 2025 (Mar 2025) | $0.17B | $0.06B | $-105.99M | -168.9% |
| FQ4 2024 (Dec 2024) | $0B | $-0.09B | $-85.19M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.11B | $114M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.11B | $105M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.11B | $105M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.08B | $75M | 100% |